Kolexia
Lassailly Guillaume
Gastro-entérologie
Hôpital Huriez
Lille, France
93 Activités
32 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Fibrose Stéatose hépatique non alcoolique Hépatite Cirrhose du foie Stéatose hépatique Hépatite alcoolique Carcinome hépatocellulaire Carcinomes Maladies du foie

Industries

Ipsen
5 collaboration(s)
Dernière en 2021
Novartis
1 collaboration(s)
Dernière en 2021
Sandoz
1 collaboration(s)
Dernière en 2023
Gilead
1 collaboration(s)
Dernière en 2022

Dernières activités

Performance of non-invasive tests for liver fibrosis and resolution after bariatric surgery.
Metabolism: clinical and experimental   12 janvier 2024
Exploring the links between types 2 diabetes and liver-related complications: A comprehensive review.
United European gastroenterology journal   16 décembre 2023
Good outcome of liver transplantation in patients with pre-existing renal cell carcinoma.
Clinics and research in hepatology and gastroenterology   13 décembre 2023
Conventional cytotoxic chemotherapy for gastrointestinal cancer in patients with cirrhosis: A multicentre case-control study.
Liver international : official journal of the International Association for the Study of the Liver   30 novembre 2023
Nash : la chir bariatrique améliore la survie
Youtube @ CREGG   17 novembre 2023
The ubiquitin-like modifier FAT10 is induced in MASLD and impairs the lipid-regulatory activity of PPARα.
Metabolism: clinical and experimental   03 novembre 2023
Time-of-day-dependent variation of the human liver transcriptome and metabolome is disrupted in MASLD.
JHEP reports : innovation in hepatology   27 octobre 2023
Bariatric surgery and liver transplantation, here we are now: A French nationwide retrospective study.
Clinics and research in hepatology and gastroenterology   21 juin 2023
NASH et chirurgie de l’obésité
Nutrition Clinique et Métabolisme   28 mars 2023
LLIFT: Diagnostic Accuracy of the "LLIFT", a Novel Non-invasive Biomarker for the Diagnosis of Non Alcoholic Fatty Liver (NAFL) and SteatoHepatitis (NASH) in a Population With High Risk of Metabolic Syndrome"
Essai Clinique (CHU Lille)   26 janvier 2023